HilleVax, Inc.
HLVX
$1.86
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -33.82% | -15.38% | -5.88% | 12.39% | 46.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -77.94% | -71.76% | -22.21% | 15.05% | 19.04% |
| Operating Income | 77.94% | 71.76% | 22.21% | -15.05% | -19.04% |
| Income Before Tax | 87.06% | 8.15% | 18.83% | -45.75% | -74.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 87.06% | 8.15% | 18.83% | -45.75% | -74.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 87.06% | 8.15% | 18.83% | -45.75% | -74.16% |
| EBIT | 77.94% | 71.76% | 22.21% | -15.05% | -19.04% |
| EBITDA | 78.38% | 72.65% | 22.83% | -13.90% | -17.47% |
| EPS Basic | 87.45% | -76.17% | 35.83% | -12.47% | -35.68% |
| Normalized Basic EPS | 79.72% | 62.46% | 35.83% | 6.70% | 4.94% |
| EPS Diluted | 87.45% | -76.67% | 35.83% | -12.16% | -35.68% |
| Normalized Diluted EPS | 79.72% | 62.46% | 35.83% | 6.70% | 4.94% |
| Average Basic Shares Outstanding | 3.14% | 4.26% | 26.49% | 29.58% | 28.36% |
| Average Diluted Shares Outstanding | 3.14% | 4.26% | 26.49% | 29.58% | 28.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |